Clinical Trial Update: Naldebain for Control of Post-Cesarean Section Pain [Phase 2]

View source ↗

Summary

Phase 2 trial update for Naldebain in managing post-cesarean section pain is currently in unknown status according to the clinical trials entry.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cesarean Section
• Postoperative Pain

Drugs mentioned

• Naldebain (dinalbuphine ester)

Snippet

Sponsor: E-DA Hospital | Conditions: Post Operative Pain, Acute, Post Operative Pain, Chronic | Phase 2 | Status: UNKNOWN